Skip to main content
Gulf Coast
Resilience System
Main menu
Home
Forum
Groups
Maps
FAQs
We Need Answers’: Hurricane Michael Leaves Florida Residents Desperate for Aid
User login
Username
*
Password
*
Create new account
Request new password
lake
What is the weather on the sun
Search form
Search
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
Pending House Republican bill would make it difficult for states to administer food stamp benefits
Opinion: Trump administration red tape and pending legislation could devastate medical care for millions of Americans
Analysis of impact of pending budget bill on Obamacare coverage
Issues in Getting a COVID Vaccine This Fall--overview
Measles update: First cases in Arizona, more in Texas, officially ended in Pennslvania and Michigan
Recent Comments
More details of Trump administration's proposed budget cuts
1 week 1 day ago
Analysis: New CDC Covid statements appear to contradict Kennedy
1 week 6 days ago
Effects of changes in administration's COVID vaccine policy
2 weeks 10 hours ago
The universal flu vaccine project puzzles vaccine experts
4 weeks 1 day ago
Who's online
There are currently 0 users online.
You are here
Home
Merck's COVID treatment expected to launch in China on Friday
Primary tabs
View
(active tab)
Workflow
Wed, 2023-01-11 09:50 —
mike kraft
Merck's COVID treatment expected to launch in China on Friday
Merck & Co's COVID-19 antiviral treatment molnupiravir is expected to be launched in the Chinese market on Friday, Sinopharm's president Liu Yong was quoted as saying by state-backed media outlet Kankan News on Wednesday.
Reuters
Reuters
Country / Region Tags:
China
Global
United States
General Topic Tags:
COVID-19
Treatments
Disease
Health
Mutations
Pandemics
Public Health
Science
Problem, Solution, SitRep, or ?:
Situation Report
Groups this Group Post belongs to:
- Private group -
Log in
or
register
to post comments
howdy folks
Page loaded in 0.292 seconds.
Recent Comments